Speakers

Matt Beyersdorf

Director of Intellectual Property

BioNTech

Kady Bruce, Ph.D.

Head of Intellectual Property

Crescent Biopharma

Larry Coury

Senior Vice President, Chief Intellectual Property Counsel, Assoc. General Counsel for IP Litigation

Regeneron Pharmaceuticals, Inc.

Sarah Fashena

VP, Head of Intellectual Property Strategy

Ascidian Therapeutics, Inc.

Allison Gilder

Partner

Foley Hoag

Colin Heitzmann

Vice President of Intellectual Property

Travere Therapeutics

Emily Johnson

Head of Global Intellectual Property Policy, Innovation Law

Bristol Myers Squibb

Jim Kastenmayer

General Counsel, Compliance Officer, and Secretary

ArriVent BioPharma

Sherry Knowles

Principal

Knowles Intellectual Property Strategies

Kwame Mensah

Assistant General Counsel, Oncology Biologics IP

AstraZeneca

Adam Perlman

Senior Vice President, Deputy General Patent Counsel-IP Litigation and IP Strategy

Eli Lilly

John Rearick, Ph.D.

Partner

Cooley LLP

Corey Salsberg

Vice President and Global Head of IP Affairs

Novartis

Colin Sandercock

Vice President & General Counsel

Cue Biopharma, Inc.

Runa Shah-Qaderi

Intellectual Property Manager

Cellphire Therapeutics